E7070
Phase 2Terminated 1 views this week 0 watching💤 Quiet
Interest: 27/100
27
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metastatic Breast Cancer
Conditions
Metastatic Breast Cancer
Trial Timeline
Dec 1, 2004 → Sep 1, 2007
NCT ID
NCT00165880About E7070
E7070 is a phase 2 stage product being developed by Eisai for Metastatic Breast Cancer. The current trial status is terminated. This product is registered under clinical trial identifier NCT00165880. Target conditions include Metastatic Breast Cancer.
What happened to similar drugs?
20 of 20 similar drugs in Metastatic Breast Cancer were approved
Approved (20) Terminated (8) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00165867 | Phase 2 | Completed |
| NCT00165594 | Phase 1/2 | Terminated |
| NCT00165880 | Phase 2 | Terminated |
| NCT00080197 | Phase 2 | Completed |
| NCT00165854 | Phase 2 | Completed |
| NCT00059735 | Phase 2 | Completed |
Competing Products
20 competing products in Metastatic Breast Cancer